Can-Fite’s data will be presented at the 2025 ASCO Gastrointestinal Cancers Symposium Can-Fite enrolls patients for its pivotal Phase III ...

Nov. 12, 2024 — Researchers have developed a patch for easier and more effective treatment of psoriasis. The method may also be used in treatment of other ...

Dec. 13, 2024 — New research highlights the possibility of screening people with type 2 diabetes for liver damage at the same time as they undergo screening for eye ... Microbiome Changes in ...

Psoriasis is a chronic (long-term) inflammatory condition that causes red, itchy patches on the skin. It can appear anywhere on the body, but when it affects the genitals, it is referred to as ...

From dentistry to medicine to electric vehicles, Temple University researchers expand the frontiers of knowledge and ...

The Barbara Ann Karmanos Cancer Institute in Detroit says the new TheraBionic P1 device, an FDA-approved, at-home treatment, now is available to treat advanced liver cancer. Karmanos Cancer Center is ...

Google app teardown hints at free Gemini Advanced for the Galaxy S25 series when the phone launches. Different Galaxy S25 models could get varying durations of free access, ranging from three ...

Tildrakizumab was well tolerated and achieved sustained response in patients with moderate to severe plaque psoriasis of the scalp in a phase 3 study. This study excluded patients with ...

Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory decisions.

Itacitinib adipate is under clinical development by Incyte and currently in Phase II for Myelodysplastic Syndrome.

Ibcasertib is under clinical development by Shenzhen Chipscreen Biosciences and currently in Phase II for Non-Hodgkin Lymphoma.

Key Takeaways from the Pacemakers Market Report .In December 2024:- NCH Healthcare System, Inc. dba Naples Comprehensive Health and dba NCH- This is a prospective, randomized controlled (1:1) ...